DelveInsight has launched a new report on Short Bowel Syndrome – Epidemiology Forecast to 2030.
DelveInsight’s ‘Short Bowel Syndrome – Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Short Bowel Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key facts of the Report:
- The prevalence of Short Bowel Syndrome in Germany is 34 per million inhabitants.
- The most common cause of Short Bowel Syndrome in infants and babies is necrotizing enterocolitis (NEC) which accounts for up to 40% of SBS patients.
- Short Bowel Syndrome affected not more than 0.35 in 10,000 people in the European Union (EU).
- Several conditions requiring intestinal resection lead to Short Bowel Syndrome. These conditions include postoperative (25%), irradiation/cancer (24%), mesenteric vascular disease (22%), Crohn’s disease (16%), and other benign causes (13%).
“According to DelveInsight, women are more likely to suffer from Short Bowel Syndrome as compared to men.”
Short bowel syndrome (SBS) is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine.
SBS is generally broken down into individuals in whom the disorder is acquired during life and newborns in which the disorder is present at birth (congenital). Acquired short bowel syndrome is more common than the congenital form of the disorder.
The specific symptoms and severity of SBS vary from one person to another. Diarrhea is common, often severe and can cause dehydration, which can even be life-threatening. SBS can lead to malnutrition, unintended weight loss, and additional symptoms may be due to the loss of essential vitamins and minerals.
SBS is most commonly associated with surgical removal (resection) of half or more of the small intestine. Such surgery is performed to treat intestinal diseases such as Crohn’s disease, injury or trauma to the small bowel, or congenital birth defects.
“DelveInsight estimates an increase in Short bowel syndrome Market Size during the study period, 2017 – 2030.”
Request a Free Sample Report @ https://www.delveinsight.com/sample-request/short-bowel-syndrome-epidemiology-forecast
Scope of the Report
- The Short Bowel Syndrome report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
- The Short Bowel Syndrome Epidemiology Report and Model provide an overview of the risk factors and global trends of Short Bowel Syndrome in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
- The report provides insight about the historical and forecasted patient pool of Short Bowel Syndrome in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
- The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
- The report assesses the disease risk and burden and highlights the unmet needs of Short Bowel Syndrome
- The report provides the segmentation of the Short Bowel Syndrome epidemiology
KOL- Views
We interview, KOLs and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
Key Questions Answered
- What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Short Bowel Syndrome?
- What are the key findings pertaining to the Short Bowel Syndrome epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
- What would be the total number of patients of Short Bowel Syndrome across the 7MM during the forecast period (2017-2030)?
- Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
- At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
- What is the disease risk, burden and unmet needs of the Short Bowel Syndrome?
- What are the currently available treatments of Short Bowel Syndrome?
Request a Free Sample Report @ https://www.delveinsight.com/sample-request/short-bowel-syndrome-epidemiology-forecast
Reasons to buy
- The Short Bowel Syndrome Epidemiology report will allow the user to –
- Develop business strategies by understanding the trends shaping and driving the global Short Bowel Syndrome market
- Quantify patient populations in the global Short Bowel Syndrome market to improve product design, pricing, and launch plans
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Short Bowel Syndrome therapeutics in each of the markets covered
- Understand the magnitude of Short Bowel Syndrome population by its epidemiology
- The Short Bowel Syndrome Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Key Assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
Related Reports:
Short Bowel Syndrome- Market Insight, Epidemiology and Market Forecast -2030
The Short Bowel Syndrome market report provides current treatment practices, emerging drugs, Short Bowel Syndrome market share of the individual therapies, current and forecasted Short Bowel Syndrome market Size from 2017 to 2030 segmented by seven major markets.
Short Bowel Syndrome – Epidemiology Forecast to 2030
The Short Bowel Syndrome epidemiology covered in the report provides historical as well as forecasted Short Bowel Syndrome epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/